In addition, liensinine may block the autophagosome-lysosome fusion stage of autophagy, by inhibiting the recruitment of RAB7A, while the inhibition of autophagy using liensinine with chemotherapeutic agents enhanced apoptosis in BC cells [144]. The gene discussed is RAB7A; the disease is breast cancer.